BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28582347)

  • 1. Tissue-based Immunohistochemical Biomarker Expression in Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review.
    Lee S; Sahasrabuddhe VV; Mendoza-Cervantes D; Zhao R; Duggan MA
    Int J Gynecol Pathol; 2018 Mar; 37(2):128-140. PubMed ID: 28582347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
    Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
    Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric-type adenocarcinoma in situ of uterine cervix: cytological and histopathological features of two cases.
    Yuan CT; Lin MC; Kuo KT; Wang TH; Mao TL
    Virchows Arch; 2016 Sep; 469(3):351-6. PubMed ID: 27334141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'.
    Mikami Y; Kiyokawa T; Hata S; Fujiwara K; Moriya T; Sasano H; Manabe T; Akahira J; Ito K; Tase T; Yaegashi N; Sato I; Tateno H; Naganuma H
    Mod Pathol; 2004 Aug; 17(8):962-72. PubMed ID: 15143335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
    Cina SJ; Richardson MS; Austin RM; Kurman RJ
    Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of adenocarcinoma in situ arising in lobular endocervical glandular hyperplasia indicating localization of mucin on the cluster surface as an early cytological finding of malignant transformation.
    Okuyama R; Hashimoto H; Miura T; Sugita M; Arai M; Tsunoda H; Sasajima Y; Horiuchi H
    Diagn Cytopathol; 2017 Sep; 45(9):842-847. PubMed ID: 28449203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
    Asaka S; Nakajima T; Momose M; Miyamoto T; Uehara T; Ota H
    Virchows Arch; 2019 Jan; 474(1):79-86. PubMed ID: 30324235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
    Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
    Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
    Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
    Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV-negative Gastric Type Adenocarcinoma In Situ of the Cervix: A Spectrum of Rare Lesions Exhibiting Gastric and Intestinal Differentiation.
    Talia KL; Stewart CJR; Howitt BE; Nucci MR; McCluggage WG
    Am J Surg Pathol; 2017 Aug; 41(8):1023-1033. PubMed ID: 28394803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine cervical carcinomas associated with lobular endocervical glandular hyperplasia.
    Tsuji T; Togami S; Nomoto M; Higashi M; Fukukura Y; Kamio M; Yonezawa S; Douchi T
    Histopathology; 2011 Jul; 59(1):55-62. PubMed ID: 21771026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and Müllerian-type.
    Asaka S; Nakajima T; Kugo K; Kashiwagi R; Yazaki N; Miyamoto T; Uehara T; Ota H
    Virchows Arch; 2020 Apr; 476(4):499-510. PubMed ID: 31932920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the insulin-like growth factor-II mRNA-binding protein 3 (IMP3) and carcinoembryonic antigen (CEA) in mucinous minimal deviation adenocarcinoma.
    He Y; Li L; Jiang W; Wang DQ; Xu L; Huang Q; Zhang Y; Yang KX
    Pathol Res Pract; 2011 May; 207(5):295-9. PubMed ID: 21497449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma ('adenoma malignum') and endocervical glandular hyperplasia: a study using oestrogen receptor and alpha-smooth muscle actin double immunostaining.
    Mikami Y; Kiyokawa T; Moriya T; Sasano H
    Histopathology; 2005 Feb; 46(2):130-6. PubMed ID: 15693884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobular endocervical glandular hyperplasia as a presumed precursor of cervical adenocarcinoma independent of human papillomavirus infection.
    Nara M; Hashi A; Murata S; Kondo T; Yuminamochi T; Nakazawa K; Katoh R; Hoshi K
    Gynecol Oncol; 2007 Aug; 106(2):289-98. PubMed ID: 17540439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The developing spectrum of gastric-type cervical glandular lesions.
    Talia KL; McCluggage WG
    Pathology; 2018 Feb; 50(2):122-133. PubMed ID: 29233547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and 'adenoma malignum' based on common histopathological criteria.
    Tsuda H; Mikami Y; Kaku T; Hasegawa T; Akiyama F; Ohishi Y; Sasajima Y; Kasamatsu T
    Pathol Int; 2005 Jul; 55(7):412-8. PubMed ID: 15982216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.